Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Cancer Metastasis Reviews
|
February 27, 2019
Acidosis and cancer: from mechanism to neutralization
Arig Ibrahim-Hashim, Veronica Estrella
Cancer Research
|
January 18, 2008
Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44
Roozbeh Golshani, Luis Lopez, Veronica Estrella, et al.
Plos One
|
May 25, 2012
Intracellular electric field and pH optimize protein localization and movement
Jessica Cunningham, Veronica Estrella, Mark Lloyd, et al.
Plos One
|
January 26, 2019
In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes
Jung W Choi, Mikalai Budzevich, Shaowei Wang, et al.
Frontiers in Oncology
|
May 30, 2013
The role of tumor tissue architecture in treatment penetration and efficacy: an integrative study
Katarzyna A Rejniak, Veronica Estrella, Tingan Chen, et al.
Cancer Research
|
December 6, 2006
HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer
Vinata B Lokeshwar, Veronica Estrella, Luis Lopez, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
February 24, 2005
Breast health information: messages that appeal to young women and older women of color
Kim Simonian, Susan E Brown, Donna Bell Sanders, et al.
Cancer Research
|
December 8, 2022
Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells
Asmaa El-Kenawi, Anders Berglund, Veronica Estrella, et al.
International Journal of Cancer
|
January 19, 2007
HAS1 expression in bladder cancer and its relation to urinary HA test
Roozbeh Golshani, Stefan H Hautmann, Veronica Estrella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells
Warren Fiskus, Michael Pranpat, Maria Balasis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Cancer Metastasis Reviews
|
February 27, 2019
Acidosis and cancer: from mechanism to neutralization
Arig Ibrahim-Hashim, Veronica Estrella
Cancer Research
|
January 18, 2008
Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44
Roozbeh Golshani, Luis Lopez, Veronica Estrella, et al.
Plos One
|
May 25, 2012
Intracellular electric field and pH optimize protein localization and movement
Jessica Cunningham, Veronica Estrella, Mark Lloyd, et al.
Plos One
|
January 26, 2019
In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes
Jung W Choi, Mikalai Budzevich, Shaowei Wang, et al.
Frontiers in Oncology
|
May 30, 2013
The role of tumor tissue architecture in treatment penetration and efficacy: an integrative study
Katarzyna A Rejniak, Veronica Estrella, Tingan Chen, et al.
Cancer Research
|
December 6, 2006
HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer
Vinata B Lokeshwar, Veronica Estrella, Luis Lopez, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
February 24, 2005
Breast health information: messages that appeal to young women and older women of color
Kim Simonian, Susan E Brown, Donna Bell Sanders, et al.
Cancer Research
|
December 8, 2022
Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells
Asmaa El-Kenawi, Anders Berglund, Veronica Estrella, et al.
International Journal of Cancer
|
January 19, 2007
HAS1 expression in bladder cancer and its relation to urinary HA test
Roozbeh Golshani, Stefan H Hautmann, Veronica Estrella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells
Warren Fiskus, Michael Pranpat, Maria Balasis, et al.
Page
of 3